Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China
· Delayed Price · Currency is CNY 24.45
-0.21 (-0.85%)
May 30, 2025, 11:45 AM CST
SHE:300119 Revenue
Tianjin Ringpu Bio-Technology had revenue of 821.62M CNY in the quarter ending March 31, 2025, with 20.00% growth. This brings the company's revenue in the last twelve months to 3.21B, up 8.67% year-over-year. In the year 2024, Tianjin Ringpu Bio-Technology had annual revenue of 3.07B with 13.32% growth.
Revenue (ttm)
3.21B
Revenue Growth
+8.67%
P/S Ratio
3.50
Revenue / Employee
1.11M
Employees
2,900
Market Cap
11.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.07B | 360.83M | 13.32% |
| Dec 31, 2023 | 2.71B | 624.85M | 29.98% |
| Jan 1, 2023 | 2.08B | 77.11M | 3.84% |
| Jan 1, 2022 | 2.01B | 6.73M | 0.34% |
| Dec 31, 2020 | 2.00B | 533.83M | 36.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |